Merck's finances came under Washington scrutiny as Senator Ron Wyden pressed the drugmaker on how it booked profits overseas last year while its effective tax rate dropped https://t.co/O8jA9Dm1WV— Bloomberg (@business) April 4, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


